Every 8-K that Addus Homecare Corp (ADUS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ADUS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ADUS filings page.
Addus HomeCare Corporation reported that Heather Dixon, President and Chief Operating Officer, left the company on August 7, 2026. The board expressed appreciation for her leadership and contributions.
On the same date, the company appointed W. Bradley (Brad) Bickham, age 63, as Chief Operating Officer on an interim basis. Bickham previously served as President and COO from March 2021 through September 2025 and as Executive Vice President and COO from January 2017 through March 2021, and most recently was Advisor to the Chief Executive Officer.
On August 10, 2026, Addus and Bickham entered into an Employment Agreement under which he will serve as COO through July 31, 2027, unless ended earlier or extended by mutual written agreement. The agreement provides an annualized base salary of $622,000 and fixed bonuses, and includes confidentiality, non‑competition and non‑solicitation provisions. The company states there are no family relationships or related‑party transactions requiring disclosure beyond a previously filed retention and transition agreement. A press release announcing these changes and describing Addus’s home care operations was also issued.
Addus HomeCare Corporation reported higher results for the quarter ended June 30, 2026. Net service revenues were $377.4 million, an 8.0% increase from $349.4 million a year earlier. Net income rose to $27.6 million from $22.1 million, with diluted EPS of $1.49 versus $1.20.
Adjusted EBITDA increased 11.9% to $49.2 million. Adjusted net income was $32.0 million, or $1.73 per diluted share. For the first six months of 2026, net service revenues were $741.0 million, up 7.8%, and net income was $52.7 million, with adjusted EBITDA of $93.7 million.
Personal care delivered 6.8% organic revenue growth and represented 78.4% of second‑quarter revenues, hospice showed 11.1% organic revenue growth and contributed 17.0%, while home health represented 4.6%. Cash totaled $99.6 million against $64.3 million of bank debt, and operating cash flow was $40.0 million in the quarter.
Addus HomeCare Corporation reported the results of its 2026 annual stockholder meeting. Stockholders representing 17,557,334 shares of common stock, out of 18,664,776 shares outstanding and entitled to vote, were present in person or by proxy. They elected Michael Earley and Veronica Hill-Milbourne as Class II directors with terms expiring at the 2029 annual meeting, ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and approved on an advisory, non-binding basis the compensation of the company’s named executive officers as described in the proxy statement.
Addus HomeCare reported solid first-quarter 2026 growth and expanded its footprint. Net service revenues were $363.6 million, up 7.7% from 2025, while net income rose to $25.1 million and diluted EPS increased to $1.36 from $1.16. Adjusted EBITDA grew 9.7% to $44.5 million, and adjusted diluted EPS reached $1.62, up from $1.42.
Personal care, at $281.1 million, drove results with 6.5% organic revenue growth, supported by higher volumes and Texas and Illinois rate increases. Hospice revenue was $65.8 million with 7.7% organic growth, while home health revenue of $16.7 million declined modestly.
The company acquired the personal care operations of HomeCourt Home Care in Indiana, serving about 240 clients with approximately $9.7 million in annualized revenue, and signed a definitive agreement for a similarly sized Indiana business. As of March 31, 2026, Addus held $103.1 million in cash and $94.3 million in bank debt, generated $52.4 million in operating cash flow, and had $547.8 million of revolver availability.
Addus HomeCare Corporation reported strong growth for the fourth quarter and full year 2025. Fourth quarter net service revenues were $373.1 million, up 25.6% from $297.1 million a year earlier, with net income rising to $29.8 million or $1.61 per diluted share from $19.5 million or $1.07.
Adjusted EBITDA for the quarter increased 33.3% to $50.3 million. For full year 2025, net service revenues grew 23.2% to $1.42 billion, net income reached $95.9 million or $5.22 per diluted share, and adjusted EBITDA was $180.0 million, up from $140.3 million in 2024.
Personal care generated 76.6% of fourth quarter revenue, hospice 18.8%, and home health 4.6%. The company highlighted organic growth in personal care and hospice, state rate increases in Texas and Illinois, year-end cash of $81.6 million, and reduced bank debt of $124.3 million.
Addus HomeCare Corporation furnished a Form 8-K announcing its results of operations for the fiscal quarter ended September 30, 2025. The company disclosed this through a press release attached as Exhibit 99.1, which is incorporated by reference.
The filing confirms the announcement date of November 3, 2025 and lists the company’s common stock trading as ADUS on The Nasdaq Stock Market. Detailed financial and operational results are presented in the attached press release.
Addus HomeCare Corporation amended its Current Report to provide additional financial disclosure related to a completed acquisition. The company reports that on December 2, 2024 its subsidiary, Addus HealthCare, Inc., completed the acquisition of the personal care business of Curo Health Services, LLC (doing business as Gentiva). This Amendment No. 2 adds unaudited financial statements of the acquired business for the year-to-date ended December 1, 2024, and references an unaudited pro forma condensed combined statement of operations for the same period filed as Exhibit 99.1. The filing states that all other disclosures in the prior amended report remain unchanged.
Addus HomeCare Corporation (ADUS) reported the voting results from its 18 June 2025 Annual Meeting of Stockholders in an 8-K filing (Item 5.07).
- Quorum: 17,431,919 shares (94.7% of the 18,399,139 shares outstanding) were represented.
- Director elections: Class I nominees Esteban López, M.D. (93.2% support), Jean Rush (95.2% support) and Susan T. Weaver, M.D. (91.5% support) were elected for terms expiring in 2028. Broker non-votes totaled 875,876 for each nominee.
- Auditor ratification: PricewaterhouseCoopers LLP was re-appointed with 17,369,357 votes for (99.7%), 59,873 against and 2,689 abstentions.
- Say-on-Pay: Executive compensation received 15,216,859 votes for (92.0%), 1,330,522 against and 8,662 abstentions.
- Say-on-Pay frequency: An annual vote was favored by 15,903,154 shares (92.9%), compared with 632,362 for triennial, 3,984 for biennial and 16,543 abstentions. No broker non-votes.
- Board response: The Board will continue to hold the advisory Say-on-Pay vote annually until the next required frequency vote.
The filing contains no financial performance data, strategic transactions or changes to previously reported guidance. All proposals were approved by wide margins, indicating solid shareholder support for governance, compensation and audit practices.